Protalix BioTherapeutics (PLX) Total Debt Growth (1y) (2012 - 2018)
Protalix BioTherapeutics (PLX) Total Debt Growth (1y) (2012 - 2018) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5.94% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Protalix BioTherapeutics |
176.47 Mn |
165.67 Mn |
29.62 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2018 |
37.87% |
| Dec 31, 2017 |
-89.82% |
| Sep 30, 2017 |
137.43% |
| Jun 30, 2017 |
0.00% |
| Mar 31, 2017 |
0.00% |
| Dec 31, 2016 |
1,252.55% |
| Dec 31, 2013 |
-56.29% |
| Jun 30, 2013 |
-91.97% |
| Dec 31, 2012 |
-17.38% |
| Sep 30, 2012 |
-41.03% |
| Jun 30, 2012 |
5.12% |
